Difference between revisions of "Moderna v. Pfizer"
| Line 12: | Line 12: | ||
Pfizer also complains that Moderna was violating its pledge in 2020 that it refrain from enforcing any of its [[COVID vaccine]] patents while the pandemic continued. | Pfizer also complains that Moderna was violating its pledge in 2020 that it refrain from enforcing any of its [[COVID vaccine]] patents while the pandemic continued. | ||
== Moderna's Allegations == | == Moderna's Allegations == | ||
| − | <blockquote>Long before COVID-19 first emerged, Moderna recognized that mRNA had the potential to revolutionize the field of medicine. mRNA is a molecule that instructs cells to make | + | <blockquote>Long before COVID-19 first emerged, Moderna recognized that mRNA had the potential to revolutionize the field of medicine. mRNA is a molecule that instructs cells to make particular proteins. Unlike traditional vaccines and therapeutics, mRNA medicines harness the body’s own cellular machinery to make proteins themselves that can treat or prevent disease. mRNA medicines use a specific nucleotide sequence to encode instructions to make the exact |
| − | particular proteins. Unlike traditional vaccines and therapeutics, mRNA medicines harness the | + | protein needed for a particular disease. This makes mRNA medicines a powerful tool that can be programmed to target specific diseases. However, before Moderna began its research, nobody had figured out how to make or use mRNA medicines successfully. ...<ref>Moderna Complaint Para. 42</ref></blockquote> |
| − | body’s own cellular machinery to make proteins themselves that can treat or prevent disease. | ||
| − | mRNA medicines use a specific nucleotide sequence to encode instructions to make the exact | ||
| − | protein needed for a particular disease. This makes mRNA medicines a powerful tool that can be | ||
| − | programmed to target specific diseases. However, before Moderna began its research, nobody had figured out how to make or use mRNA medicines successfully. ...<ref>Moderna Complaint Para. 42</ref></blockquote> | ||
== See also == | == See also == | ||
Revision as of 07:56, January 10, 2023
Moderna v. Pfizer and BioNTech is a patent infringement lawsuit filed in late August 2022,[1] in both federal court in Massachusetts (typically Boston) and the Germany Regional Court of Düsseldorf.[2] BioNTech is a vaccine partner of Pfizer.
As explained by the Wall Street Journal:
| “ | Moderna Inc. sued rival Covid-19 vaccine makers Pfizer Inc. and BioNTech SE, alleging that the companies’ shot infringes on key intellectual property owned by Moderna.
Pfizer and BioNTech’s vaccine relies on messenger RNA technology that Moderna had developed and patented years ago, including a chemical modification that avoids prompting an undesirable immune response, Moderna said in lawsuits filed [on August 26, 2022]. |
” |
Moderna alleges two central infringements on its patents by defendants: first, that Pfizer copied the same Moderna modification to mRNA that stablizes the molecule "long enough to program human cells to produce the crucial spike protein that triggers an immune response against Covid."[3] Second, Moderna alleges that defendants use "the same full-length spike protein in its Covid shots. Moderna says it demonstrated a full spike produced an immune response in 2015 when it developed an mRNA vaccine against the Middle East Respiratory Syndrome. That vaccine never went to market."[3]
Pfizer and BioNTech countersued when they filed their answer to Moderna's lawsuit. Moderna alleged that the rival mRNA vaccines are so similar that it constitutes a patent infringement due to mRNA and lipid nanoparticles in both of the vaccines. Pfizer and BioNTech deny this and assert that their vaccine is “undeniably different” from Moderna's, by using a different mRNA structure and different lipids from Moderna's patented mRNA vaccine.
Pfizer also complains that Moderna was violating its pledge in 2020 that it refrain from enforcing any of its COVID vaccine patents while the pandemic continued.
Moderna's Allegations
Long before COVID-19 first emerged, Moderna recognized that mRNA had the potential to revolutionize the field of medicine. mRNA is a molecule that instructs cells to make particular proteins. Unlike traditional vaccines and therapeutics, mRNA medicines harness the body’s own cellular machinery to make proteins themselves that can treat or prevent disease. mRNA medicines use a specific nucleotide sequence to encode instructions to make the exact protein needed for a particular disease. This makes mRNA medicines a powerful tool that can be programmed to target specific diseases. However, before Moderna began its research, nobody had figured out how to make or use mRNA medicines successfully. ...[4]
See also
References
- ↑ https://www.wsj.com/articles/moderna-sues-pfizer-and-biontech-alleging-infringement-of-mrna-patents-11661519898
- ↑ https://investors.modernatx.com/news/news-details/2022/Moderna-Sues-Pfizer-and-BioNTech-for-Infringing-Patents-Central-to-Modernas-Innovative-mRNA-Technology-Platform/default.aspx
- ↑ 3.0 3.1 https://www.cnbc.com/2022/12/06/pfizer-rejects-moderna-claim-it-copied-covid-vaccine-accuses-rival-of-rewriting-history.html
- ↑ Moderna Complaint Para. 42